Status:
COMPLETED
Prospective Observational Lymphoedema Intensive Treatment
Lead Sponsor:
Thuasne
Conditions:
Lymphoedema
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational study was to describe usual practices in lymphedema management in France. It was the opportunity to assess the effects of these practices on lymphedema volume in a large...
Detailed Description
Lymphoedema is commonly treated according a strategy called Complex Decongestive Therapy (CDT). This CDT is usually composed of 2 different treatment phases. The first phase is an acute phase which ai...
Eligibility Criteria
Inclusion
- consecutive adult patients
- hospitalized with a clinical diagnosis of unilateral stage II-III upper or lower limb lymphoedema of any etiology
- indication for intensive decongestive therapy (IDT)
Exclusion
- bilateral lymphedema,
- lymphedema of both upper and lower limbs,
- intensive decongestive therapy in the previous 6 months,
- cancer recurrence,
- systolic pressure index \< 0.5
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT01864044
Start Date
September 1 2009
End Date
December 1 2012
Last Update
November 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.